Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies: A pilot study of treatment with intravenous immunoglobulin

Acta Obstetricia et Gynecologica Scandinavica

Volumn 75, Issue 10, 1996, Pages 922-926

  Marzusch, Klaus ^a   Dietl, Johannes ^a   Klein, Reinhild ^b   Hornung, Daniela ^c   Neuer, Andreas ^c   Berg, Peter A ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Antiphospholipid antibodies; Intravenous immunoglobulin; Pregnancy loss; Recurrent spontaneous abortion

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN 7S; PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SPONTANEOUS ABORTION; TREATMENT OUTCOME;

EID: 0030459515     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349609055029     Document Type: Article

References (36)

1. Boey ML, Colaco CB, Gharavi AK, Elkon KB, Loizou S, Hughes GRV. Thrombosis in systemic lupus erythematosus: Striking association with the presence of circulating lupus anticoagulant. Br Med J 1983; 287: 1021-3.
2. Harris EN, Gharavi AK, Boey ML. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-4.
3. Mannoussakis MN, Gharavi AK, Drosos AA, Kitridou RC, Moutsopoulos HM. Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol 1987; 44: 297-307.
4. Harris EN, Chan JK, Asherson RA, Aber VR, Gharavi AK, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153-6.
5. Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313: 152-6.
6. Unander AM, Norberg R, Hahn L, Arfors L. Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion. Am J Obstet Gynecol 1987; 156: 114-9.
7. Silver RM, Drapner ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: A historic cohort study. Obstet Gynecol 1994; 83: 372-7.
8. Matzner W, Chong P, Xu G, Ching W. Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions. J Reprod Med 1994; 39: 27-30.
9. Carreras LO, Vermylen JG. Lupus anticoagulant and thrombosis: Possible role of inhibition of prostaglandin formation. Thromb Haemostas 1982; 48: 28-31.
10. Asherson RA, Harris EN. Anticardiolipin antibodies in the detection of autoimmune disorders. Int Med 1987; 8: 73-80.
11. Lyden TW, Ng AK, Rote NJ. Modulation of phosphatidylserine epitope expression on BeWo cells during forskolin treatment. Am J Reprod Immunol 1992; 27: 24-9.
12. Triplett DA, Harris EN. Antiphospholipid antibodies and reproduction. Am J Reprod Immunol 1989; 21: 123-31.
13. Out HJ, Bruinse HW, Derksen RHWM. Antiphospholipid antibodies and pregnancy loss. Hum Reprod 1991; 6: 889-97.
14. MacLean MA. Cumming GP, McCall F, Walker ID, Walker JJ. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gynaecol 1994; 101: 103-6.
15. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313: 1322-6.
16. Asherson RA, Harris EN. Anticardiolipin antibodies - clinical associations. J Postgrad Med J 1986; 62: 1081-7.
17. Scott JR, Rote NS, Branch DW. Immunologic aspects of recurrent abortion and fetal death. Obstet Gynecol 1987; 70: 645-6.
18. Cowchock S. Autoantibodies and pregnancy wastage. Am J Reprod Immunol 1991; 26: 38-41.
19. Orvieto R, Achiron A, Ben-Rafael Z, Achiron R. Intravenous immunoglobulin treatment for recurrent abortions caused by antiphospholipid antibodies. Fertil Steril 1991; 56: 1013-20.
20. Carreras LO, Perez GN, Vega HR, Casavilla F. Lupus anticoagulant and recurrent fetal loss: Successful treatment with gammaglobulin. Lancet 1988; 2: 393-4.
21. MacLachlan NA, Letsky E, DeSwiet M, Rodeck CH. The use of intravenous immunoglobulin therapy in the management of anti-phospholipid antibody associated pregnancies. Clin Exp Rheumatol 1990; 8: 221-4.
22. Kaaja R, Julkunen H, Ämmälä P, Palosuo T, Kurki P. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Acta Obstet Gynecol Scand 1993; 72: 63-6.
23. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
24. Branch DW, Rote NS, Scott JR. The demonstration of lupus anticoagulant by an enzyme-linked immunoadsorbent assay. Clin Immunol Immunopathol 1986; 39: 298-307.
25. Lopez-Soto A, Casals FJ, Font J, Cervera R, Ingelmo M. Detection of antiphospholipid antibodies by an ELISA-method with bovine thromboplastin as antigen. Thromb Res 1989; 53: 623-8.
26. Balasch J, Carmona F, Lopez-Soto A, Font J, Creus M, Fabrgues F et al. Low-dose aspirin for prevention of pregnancy losses in women with primary anti-phospholipid syndrome. Hum Reprod 1993; 8: 2234-9.
27. Vogt E, Lyden TW, Rote NJ. Reactivity of human IgM anti-phospholipid antibodies against placental trophoblast. Am J Reprod Immunol 1992; 27: 25-9.
28. Reece EA, Gabrielli S, Cullen MT, Zheng XZ, Hobbins JC, Harris EN. Recurrent adverse pregnancy outcome and antiphospholipid antibodies. Am J Obstet Gynecol 1990; 163: 162-9.
29. Lubbe WF, Butler WS, Palmer SJ, Liggins GC. Lupus anticoagulant and pregnancy. Br J Obstet Gynaecol 1984; 91: 357-63.
30. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989; 160: 439-43.
31. Wapner RJ, Cowchock FS, Shapiro SS. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous immunoglobulin infusions. Am J Obstet Gynecol 1989; 161: 1271-2.
32. Delfraissy JF, Tchernia G, Laurian Y, Dreyfus M, Deryeke M, Mirica C. Suppressor cell function after intravenous gamma globulin treatment in adult chronic idiopathic thrombocytopenic purpura. Br J Haematol 1985; 60: 315-22.
33. Nydegger UK. Hypothetic and established action mechanisms of therapy with immunoglobulin G. In: Imbach P. ed. Immunotherapy with intravenous immunoglobulins. Academic Press, 1991: 27-36.
34. Kimberly RP, Salmon JE, Bussell JB. Modulation of mononuclear phagocyte function by intravenous gammaglobulin. J Immunol 1987, 132. 745-50.
35. Brand A, Witvliet M, Claas FHJ. Beneficial effect of intravenous gammaglobulin in a patient with complement-mediated autoimmune thrombocytopenia due to IgM-antiplatelet antibodies. Br J Haematol 1988; 69: 507-11.
36. Rossi F, Dietrich G, Kazatchkine MD. Anti-idiotypes against autoantibodies in normal immunoglobulins: Evidence for network regulation of human autoimmune responses. Immunol Rev 1989; 110: 135-42.